It has been reported that some kinds of cancers strongly depend on the GPX4 during their pathogenesis and development, such as renal cell carcinomas, diffuse large B cell lymphomas, pancreatic cancer, prostate cancer, melanoma, and a subset of triple-negative breast cancer cell lines with glutamine deficiency (60). This evidence concerns the gene GPX4 and cancer.